Topics
AMD
Clinical Trial Closeup
Coding & Medicare
DME
Editor's Page
Genetics
Imaging & Diagnostics
News
RVO
Stem Cells
Surgical Pearl Video
Surgical Techniques & Tools
Uveitis
Vitrectomy
Current Issue
Archive
CME
Editor's Page
By Jason Hsu, MD
A heavy burden
The Solow paradox
FDA engagement
Breaking down silos
Synthetic considerations
The complement era dawns
Leave some work for tomorrow
What's in a number?
‘The FDA is on the line’
It's later than you think
OCT-ologists
Promises and pudding
2022: Banner year for clinical trials
Six and Counting
Making the pivot
Fluid is bad. Or is it?
Untapped insights
Asymptomatic patients
More balance
Year of uncertainty
The anxiety around us
Diversity and a vaccine
Quarantine
Caution ahead: Confronting DME
Too many meetings? Sign me up
Turning the tide on GA
Family of Five
Clinically relevant
In search of a better mousetrap
Weather forecasting
Load More
Current Issue
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Connect With Us
Continuing Medical Education
Breaking New Ground: Reducing Treatment Burden in nAMD
CME Monograph
View More CME
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
View More Publications
Review Of Ophthalmology
Table of Contents
Digital Edition
PDF Edition
Archives
Subscription
Solving Dry-Eye Conundrums
Survey: Cataract Surgery Snapshot
First-Line Treatment: SLT or Medication?
×
Full Image